Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan-Reference-Cited by-同舟云学术

Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan

Published:2020-01-01 Issue:1 Volume:9 Page:2157-2168
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Chen Shey-Ying¹²,Lee Yu-Lin³,Lin Yi-Chun⁴⁵,Lee Nan-Yao⁶⁷,Liao Chia-Hung⁸,Hung Yuan-Pin⁷⁹¹⁰,Lu Min-Chi¹¹¹²,Wu Jhong-Lin¹,Tseng Wen-Pin¹,Lin Chien-Hao¹,Chung Ming-Yi¹³,Kang Chun-Min¹³¹⁴,Lee Ya-Fan¹³,Lee Tai-Fen¹³,Cheng Chien-Yu⁴¹⁵,Chen Cheng-Pin⁴¹⁶,Huang Chien-Hua¹,Liu Chun-Eng⁴,Cheng Shu-Hsing⁴¹⁷,Ko Wen-Chien⁶⁷,Hsueh Po-Ren¹³¹⁸,Chen Shyr-Chyr¹

Affiliation:

1. Department of Emergency Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan

2. Center for Quality Management, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan

3. Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan

4. Division of Infectious Diseases, Department of Internal Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan

5. Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

6. Department of Internal Medicine and Center for Infection Control, College of Medicine, National Cheng Kung University Hospital, Tainan, Taiwan

7. Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan

8. Division of Infectious Diseases, Department of Internal Medicine, Ministry of Health and Welfare Nantou Hospital, Nantou, Taiwan

9. Department of Internal Medicine, Tainan Hospital, Ministry of Health & Welfare, Tainan, Taiwan

10. Graduate Institute of Clinical Medicine, National Health Research Institutes, Tainan, Taiwan

11. Division of Infectious Diseases, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan

12. Department of Microbiology and Immunology, School of Medicine, China Medical University, Taichung, Taiwan

13. Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan

14. Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan

15. School of Public Health, National Yang-Ming University, Taipei, Taiwan

16. Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

17. School of Public Health, Taipei Medical University, Taipei, Taiwan

18. Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan

Funder

None

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1825016

Reference37 articles.

1. WHO Statement (31 January 2020). “Statement on the second meeting of the International Health Regulations. (2005). Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). World Health Organization. Retrieved 6 February 2020. Available from: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

4. World Health Organization. Coronavirus disease (COVID-2019) situation reports – 166 [cited 15 Jul 2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.

5. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals;Journal of Immunological Methods;2024-07

2. A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19;International Journal of Biological Macromolecules;2024-02

3. Performance Evaluation of Three Antibody Binding Assays, a Neutralizing Antibody Assay, and an Interferon-Gamma Release Assay for SARS-CoV-2 According to Vaccine Type in Vaccinated Group;Diagnostics;2023-12-18

4. A retrospective study of air quality associated with teratogenic pathogen screening in women of reproductive age in southern China;Environmental Science and Pollution Research;2023-06-22

5. Green-synthesized two-dimensional nanocarriers with photothermal capability for portable dual-readout immunochromatographic assay of clenbuterol;Sensors and Actuators B: Chemical;2023-01